Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD40 (clone BMS3h-1G). We employs the pGEM (CMV-mNeonGreen-IL-4-KpnI) vector components and the SynExpress system of the Exons Knockout/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
CD40
Clone
BMS3h-1G
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
mNeonGreen
Promoter
CMV
Effector Gene
IL-4
Insertion Sites
KpnI
Gene Modification
Knockout
Modification Domain
Exons
Carrier Type
pGEM
Transformation Accuracy
0.92
Cell Culture
Microcarrier Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.